Cell surface complement regulators moderate experimental myasthenia gravis pathology.
about
Pathogenesis of myasthenia gravis: update on disease types, models, and mechanismsSurvivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model studyTargeting therapy to the neuromuscular junction: proof of concept.Guidelines for pre-clinical assessment of the acetylcholine receptor--specific passive transfer myasthenia gravis model-Recommendations for methods and experimental designsApplying complement therapeutics to rare diseases.The role of complement in experimental autoimmune myasthenia gravis.
P2860
Cell surface complement regulators moderate experimental myasthenia gravis pathology.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cell surface complement regulators moderate experimental myasthenia gravis pathology.
@ast
Cell surface complement regulators moderate experimental myasthenia gravis pathology.
@en
type
label
Cell surface complement regulators moderate experimental myasthenia gravis pathology.
@ast
Cell surface complement regulators moderate experimental myasthenia gravis pathology.
@en
prefLabel
Cell surface complement regulators moderate experimental myasthenia gravis pathology.
@ast
Cell surface complement regulators moderate experimental myasthenia gravis pathology.
@en
P2860
P356
P1433
P1476
Cell surface complement regulators moderate experimental myasthenia gravis pathology.
@en
P2093
Henry J Kaminski
Jose A Halperin
P2860
P356
10.1002/MUS.23448
P50
P577
2012-10-05T00:00:00Z